|
顯示項目 212526-212575 / 2348638 (共46973頁)
<< < 4246 4247 4248 4249 4250 4251 4252 4253 4254 4255 > >>
每頁顯示[10|25|50]項目
| 臺北醫學大學 |
1994 |
Atenolol前驅藥之製備研究
|
林友慈 |
| 臺北醫學大學 |
2004 |
Atenolol與Carvedilol於高血壓大白鼠大動脈內皮細胞隙連結之差異性作用
|
李秉穎; Ping-Ying Lee |
| 國立臺灣大學 |
2010 |
AtERF1及AIL7在非生物性逆境耐受性上分別扮演的角色
|
郭瑋文; Kuo, Wei-Wen |
| 朝陽科技大學 |
2022-12-09 |
ATERRA
|
陳奕如;潘妏婷;李岱樺;蔡宜軒;張雨薇;黃沛儒 |
| 臺大學術典藏 |
2021-08-31T06:29:15Z |
Atezolizumab and Bevacizumab in Hepatocellular Carcinoma. Reply
|
Finn R.S.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-14T23:18:53Z |
Atezolizumab plus bevacizumab combination enables an unresectable hepatocellular carcinoma resectable and links immune exclusion and tumor dedifferentiation to acquired resistance
|
Wang, Yulei; Lu, Li Chun; Guan, Yinghui; MING-CHIH HO; Lu, Shan; Spahn, Jessica; CHIH-HUNG HSU |
| 臺大學術典藏 |
2022-02-07T03:29:02Z |
Atezolizumab plus bevacizumab combination enables an unresectable hepatocellular carcinoma resectable and links immune exclusion and tumor dedifferentiation to acquired resistance
|
Wang Y.; Lu L.-C.; Guan Y.; Ho M.-C.; Lu S.; Spahn J.; CHIH-HUNG HSU |
| 臺大學術典藏 |
2021-11-25T02:38:28Z |
Atezolizumab plus bevacizumab combination enables an unresectable hepatocellular carcinoma resectable and links immune exclusion and tumor dedifferentiation to acquired resistance
|
Wang, Yulei; Lu, Li-Chun; Guan, Yinghui; MING-CHIH HO; Lu, Shan; Spahn, Jessica; Hsu, Chih-Hung |
| 國家衛生研究院 |
2021-07 |
Atezolizumab plus bevacizumab for patients with advanced hepatocellular carcinoma and chronic hepatitis B virus infection with high viral load
|
Chen, S;Lai, H;Tsou, H;Shao, Y;Chang, C;Su, T;Liu, T;Chen, L;Cheng, A;Hsu, C |
| 國家衛生研究院 |
2023-06 |
Atezolizumab plus bevacizumab for patients with unresectable hepatocellular carcinoma and high hepatitis B viral load: Focusing on hepatic safety and viral kinetics
|
Chen, SC;Tsou, HHS;Lee, TY;Wang, HW;Chen, YH;Wang, TE;Su, YY;Yang, S;Chiu, CF;Liu, TW;Cheng, AL;Chen, LT;Hsu, C |
| 臺大學術典藏 |
2021-08-31T06:29:17Z |
Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma
|
Finn R.S.; Qin S.; Ikeda M.; Galle P.R.; Ducreux M.; Kim T.-Y.; Kudo M.; Breder V.; Merle P.; Kaseb A.O.; Li D.; Verret W.; Xu D.-Z.; Hernandez S.; Liu J.; Huang C.; Mulla S.; Wang Y.; Lim H.Y.; Zhu A.X.; ANN-LII CHENG; IMbrave150 Investigators |
| 臺大學術典藏 |
2022-02-21T02:04:35Z |
Atezolizumab plus Bevacizumab versus Sorafenib in the Chinese Subpopulation with Unresectable Hepatocellular Carcinoma: Phase 3 Randomized, Open-Label IMbrave150 Study
|
Qin S.; Ren Z.; Feng Y.-H.; Yau T.; Wang B.; Zhao H.; Bai Y.; Gu S.; Li L.; Hernandez S.; Xu D.-Z.; Mulla S.; Wang Y.; Shao H.; ANN-LII CHENG |
| 臺大學術典藏 |
2022-08-19T06:48:44Z |
Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study
|
Chung H.C.; Davis S.L.; Dev A.; Gane E.; George B.; He A.R.; Hochster H.; Hsu C.-H.; Ikeda M.; Lee J.; Lee M.; Mahipal A.; Manji G.; Morimoto M.; Numata K.; Pishvaian M.; Qin S.; Ryan D.; Ryoo B.-Y.; Sasahira N.; Stein S.; Strickler J.; Tebbutt N.; Chao Y.; Chen J.-S.; Bang Y.-J.; Bendell J.; Lee K.-H.; Wang Y.; Abdullah H.; Liu B.; Spahn J.; Hack S.P.; Verret W.; CHIH-HUNG HSU; Lee M.S. |
| 臺大學術典藏 |
2022-08-19T00:20:33Z |
Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study
|
Tebbutt N.; Strickler J.; Stein S.; Ryan D.; Ryoo B.-Y.; Sasahira N.; Gane E.; George B.; He A.R.; Hochster H.; CHIUN HSU; Ikeda M.; Lee J.; Lee M.; Mahipal A.; Manji G.; Morimoto M.; Numata K.; Pishvaian M.; Qin S.; Dev A.; Davis S.L.; Chung H.C.; Chen J.-S.; Chao Y.; Bendell J.; Bang Y.-J.; Lee K.-H.; He A.R.; Wang Y.; Liu B.; Abdullah H.; Hack S.P.; Spahn J.; Lee M.S.; Ryoo B.-Y.; Hsu C.-H.; Numata K.; Stein S.; Verret W. |
| 臺大學術典藏 |
2021-02-18T01:45:22Z |
Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study
|
Lee M.S.;Ryoo B.-Y.;Numata K.;Stein S.;Verret W.;Hack S.P.;Spahn J.;Liu B.;Abdullah H.;Wang Y.;He A.R.;Lee K.-H.;Bang Y.-J.;Bendell J.;Chao Y.;Chen J.-S.;Chung H.C.;Davis S.L.;Dev A.;Gane E.;George B.;He A.R.;Hochster H.;Chiun Hsu;Ikeda M.;Lee J.;Lee M.;Mahipal A.;Manji G.;Morimoto M.;Numata K.;Pishvaian M.;Qin S.;Ryan D.;Ryoo B.-Y.;Sasahira N.;Stein S.;Strickler J.;Tebbutt N.; Lee M.S.; Ryoo B.-Y.; Numata K.; Stein S.; Verret W.; Hack S.P.; Spahn J.; Liu B.; Abdullah H.; Wang Y.; He A.R.; Lee K.-H.; Bang Y.-J.; Bendell J.; Chao Y.; Chen J.-S.; Chung H.C.; Davis S.L.; Dev A.; Gane E.; George B.; He A.R.; Hochster H.; Chiun Hsu; Ikeda M.; Lee J.; Lee M.; Mahipal A.; Manji G.; Morimoto M.; Numata K.; Pishvaian M.; Qin S.; Ryan D.; Ryoo B.-Y.; Sasahira N.; Stein S.; Strickler J.; Tebbutt N. |
| 臺大學術典藏 |
2021-02-19T06:52:27Z |
Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study
|
Lee M.S.;Ryoo B.-Y.;Chih-Hung Hsu;Numata K.;Stein S.;Verret W.;Hack S.P.;Spahn J.;Liu B.;Abdullah H.;Wang Y.;He A.R.;Lee K.-H.;Bang Y.-J.;Bendell J.;Chao Y.;Chen J.-S.;Chung H.C.;Davis S.L.;Dev A.;Gane E.;George B.;He A.R.;Hochster H.;Chih-Hung Hsu;Ikeda M.;Lee J.;Lee M.;Mahipal A.;Manji G.;Morimoto M.;Numata K.;Pishvaian M.;Qin S.;Ryan D.;Ryoo B.-Y.;Sasahira N.;Stein S.;Strickler J.;Tebbutt N.; Lee M.S.; Ryoo B.-Y.; CHIH-HUNG HSU; Numata K.; Stein S.; Verret W.; Hack S.P.; Spahn J.; Liu B.; Abdullah H.; Wang Y.; He A.R.; Lee K.-H.; Bang Y.-J.; Bendell J.; Chao Y.; Chen J.-S.; Chung H.C.; Davis S.L.; Dev A.; Gane E.; George B.; He A.R.; Hochster H.; CHIH-HUNG HSU; Ikeda M.; Lee J.; Lee M.; Mahipal A.; Manji G.; Morimoto M.; Numata K.; Pishvaian M.; Qin S.; Ryan D.; Ryoo B.-Y.; Sasahira N.; Stein S.; Strickler J.; Tebbutt N. |
| 國家衛生研究院 |
2025-01 |
Atezolizumab, bevacizumab, pemetrexed and platinum for EGFR-mutant NSCLC patients after EGFR TKI failure: A phase II study with immune cell profile analysis
|
Wu, SG;Ho, CC;Yang, JC;Yu, SH;Lin, YF;Lin, SC;Liao, BC;Yang, CY;Lin, YT;Yu, CJ;Chuang, YT;Liao, WY;Yap, KY;Kou, WS;Shih, JY |
| 臺北醫學大學 |
2014 |
ATF3 PROTECT AGAINST PRESSURE OVERLOAD HEART FAILURE VIA BECLIN-1 PATHWAY
|
Cheng, C.F.;Li, S.F.;Lin, H. |
| 臺北醫學大學 |
2013 |
ATF3 Protects against LPS-Induced Inflammation in Mice via Inhibiting HMGB1 Expression
|
PF, Lia;CF, Cheng;Lin, H;TL, Tseng;HH, Chen;SH, Chen |
| 臺北醫學大學 |
2013 |
ATF3 Protects against LPS-Induced Inflammation in Mice via Inhibiting HMGB1 Expression
|
Lia, PF;Cheng, CF;Lin, H;Tseng, TL;Chen, HH;Chen, SH |
| 臺北醫學大學 |
2014 |
ATF3 Protects Against Pressure Overload Heart Failure Via Autophagy Molecule Beclin-1 Pathway
|
Lin, H;HF, Li;HH, Chen;PF, Lai;SH, Juan;JJ, Chen;CF, Cheng |
| 臺北醫學大學 |
2014 |
ATF3 Protects Against Pressure Overload Heart Failure Via Autophagy Molecule Beclin-1 Pathway
|
Lin, H;Li, HF;Chen, HH;Lai, PF;Juan, SH;Chen, JJ;Cheng, CF. |
| 臺北醫學大學 |
2021-04 |
ATF3-Expressing Large-Diameter Sensory Afferents at Acute Stage as Bio-Signatures of Persistent Pain Associated with Lumbar Radiculopathy
|
Jiann Her Lin, Yu Wen Yu, Yu Chia Chuang, Cheng Han Lee, Chih Cheng Chen; 林建和 |
| 臺大學術典藏 |
2022-09-05T06:38:52Z |
ATF6α downregulation of PPARα promotes lipotoxicity-induced tubulointerstitial fibrosis
|
TZU-MING JAO; Nangaku M.; Wu C.-H.; Sugahara M.; Saito H.; Maekawa H.; Ishimoto Y.; Aoe M.; Inoue T.; Tanaka T.; Staels B.; Mori K.; Inagi R. |
| 國立彰化師範大學 |
2005-03 |
ATF: An Adaptive Three-Layer Framework for Inter-Stream Synchronization of SMIL Multimedia Presentations
|
Chang, Ing-Chau; Hsieh, Sheng-Wen |
| 國立臺灣大學 |
2009 |
ATF家族成員的上游開放閱讀框架(uORF)對於調控其轉譯作用之探討
|
陳明達; Chen, Ming-Ta |
| 國立臺灣大學 |
2011 |
Atg1-mediated myosin II activation regulates autophagosome formation during starvation-induced autophagy
|
Tang, Hong-Wen; Wang, Yu-Bao; Wang, Shiu-Lan; Wu, Mei-Hsuan; Lin, Shu-Yu; Chen, Guang-Chao |
| 國立臺灣大學 |
2007 |
Atg19 Mediates a Dual Interaction Cargo Sorting Mechanism in Selective Autophagy
|
Chang, Chiung-Ying; Huang, Wei-Pang |
| 國立臺灣大學 |
2010 |
Atg1在果蠅發育上的調控基因篩選分析
|
莊麗瑾; Chuang, Li-Jin |
| 國立臺灣大學 |
2007 |
Atg1在細胞自噬和細胞凋亡之探討
|
唐弘文; Tang, Hong-Wen |
| 國立高雄第一科技大學 |
2014.10 |
ATG4B promotes colorectal cancer growth independent of autophagic flux
|
Liu, Pei-Feng;Leung, Chung-Man;Chang, Yu-Hsiang;Cheng, Jin-Shiung;Chen, Jih-Jung;Weng, Chung-Jeu;Tsai, Kuo-Wang;Hsu, Chien-Jen;Liu, Yen-Chen;Hsu, Ping-Chi;Pan, Hung-Wei;Shu, Chih-Wen; 許昺奇 |
| 國立臺灣大學 |
2012 |
ATG4B和LC3-I交互作用對細胞自噬的影響
|
林佩璇; Lin, Pei-Shuan |
| 嘉南藥理大學 |
2012 |
Atg5 在 ANE 30-100K 所誘導的自體吞噬中扮演的角色
|
許凱程 |
| 臺大學術典藏 |
2020-07-01T06:33:13Z |
Atg9 antagonizes TOR signaling to regulate intestinal cell growth and epithelial homeostasis in Drosophila
|
Wen J.-K.;Wang Y.-T.;Chih-Chiang Chan;Hsieh C.-W.;Liao H.-M.;Hung C.-C.;Chen G.-C.; Wen J.-K.; Wang Y.-T.; CHIH-CHIANG CHAN; Hsieh C.-W.; Liao H.-M.; Hung C.-C.; Chen G.-C. |
| 國家衛生研究院 |
2013-12 |
Atg9 interacts with dTRAF2/TRAF6 to regulate oxidative stress-induced JNK activation and autophagy induction
|
Tang, HW;Liao, HM;Peng, WH;Lin, HR;Chen, CH;Chen, GC |
| 國立臺灣大學 |
2009 |
Atg9之轉譯後修飾與運輸在細胞自噬上所扮演的角色
|
張享恩; Chang, Hsiang-En |
| 國立臺灣大學 |
2010 |
Atg9磷酸化修飾對其細胞內運輸及細胞自噬之影響
|
黃植虹; Huang, Chih-Hung |
| 國立臺灣大學 |
2011 |
AtGASA4在紅外光訊息傳遞中之功能性研究
|
吳牧寰; Wu, Mu-Huan |
| 國立成功大學 |
2022 |
ATHENA detector proposal - a totally hermetic electron nucleus apparatus proposed for IP6 at the Electron-Ion Collider
|
Adam, J.;Adamczyk, L.;Agrawal, N.;Aidala, C.;Akers, W.;Alekseev, M.;Allen, M.M.;Ameli, F.;Angerami, Angerami A.;Antonioli, P.;Apadula, N.J.;Aprahamian, Aprahamian A.;Armstrong, W.;Arratia, M.;Arrington, J.R.;Asaturyan, Asaturyan A.;Aschenauer, E.C.;Augsten, K.;Aune, S.;Bailey, K.;Baldanza, C.;Bansal, M.;Barbosa, F.;Barion, L.;Barish, K.;Battaglieri, M.;Bazilevsky, A.;Behera, N.K.;Berdnikov, V.;Bernauer, J.;Berriaud, C.;Bhasin, A.;Bhattacharya, D.S.;Bielcik, J.;Bielcikova, J.;Bissolotti, C.;Boeglin, W.;Bondì, M.;Borri, M.;Bossù, F.;Bouyjou, F.;Brandenburg, J.D.;Bressan, A.;Brooks, M.;Bültmann, S.L.;Byer, D.;Caines, H.;Calderon, De La Barca Sanchez M.;Calvelli, V.;Camsonne, A.;Cappelli, L.;Capua, M.;Castro, M.;Cavazza, D.;Cebra, D.;Celentano, A.;Chakaberia, I.;Chan, B.;Chang, W.;Chartier, M.;Chatterjee, Chatterjee C.;Chen, D.;Chen, J.;Chen, K.;Chen, Z.;Chetri, H.;Chiarusi, T.;Chiosso, M.;Chu, X.;Chwastowski, J.J.;Cicala, G.;Cisbani, E.;Cline, E.;Cloët, I.;Colella, D.;Contalbrigo, M.;Contin, G.;Corliss, R.;Corrales-Morales, Y.;Crafts, J.;Crawford, Crawford C.;Cruz-Torres, R.;D'Ago, D.;D'Angelo, Angelo A.;D'Hose, N.;Dainton, J.;Dalla, Torre S.;Dasgupta, S.S.;Dash, S.;Dashyan, N.;Datta, J.;Daugherity, M.;De, Vita R.;Deconinck, W.;Defurne, M.;Dehmelt, K.;Del, Dotto A.;Delcarro, F.;Dellacasa, G.;Demiroglu, Z.S.;Deptuch, G.W.;Desai, V.;Deshpande, A.;Devereaux, K.;Dhillon, R.;Di, Salvo R.;Dilks, C.;Dixit, Dixit D.;Dobbs, S.;Dong, X.;Drachenberg, J.;Drees, A.;Dupré, R.;Durham, M.;Dzhygadlo, R.;El, Fassi L.;Elia, D.;Epple, Epple E.;Esha, R.;Evdokimov, O.;Eyser, O.;Falchieri, D.;Fan, W.;Fantini, A.;Fatemi, R.;Fazio, S.;Fegan, S.;Filippi, A.;Fox, H.;Francisco, A.;Freeze, A.;Furletov, S.;Furletova, Y.;Gal, C.;Gardner, S.;Garg, P.;Gaskell, D.;Gates, K.;Gericke, M.T.W.;Geurts, F.;Ghosh, C.;Giacalone, M.;Giacomini, F.;Gilchrist, S.;Glazier, D.;Gnanvo, K.;Gonella, L.;Greiner, L.C.;Guerrini, N.;Guo, L.;Gupta, A.;Gupta, R.;Guryn, W.;He, X.;Hemmick, T.;Heppelmann, S.;Higinbotham, D.;Hoballah, M.;Hoghmrtsyan, A.;Hohlmann, M.;Horn, T.;Hornidge, D.;Huang, Huang H.Z.;Hyde, C.E.;Iapozzuto, P.;Idzik, M.;Jacak, B.V.;Jadhav, M.;Jain, S.;Jena, C.;Jentsch, A.;Ji, Y.;Ji, Z.;Jia, Jia J.;Jones, P.G.;Jones, R.W.I.;Joosten, S.;Joshi, S.;Kabir, L.;Kalicy, G.;Karyan, G.;Kashyap, V.K.S.;Kawall, D.;Ke, H.;Kelsey, M.;Kim, J.;Kiryluk, J.;Kiselev, A.;Klein, S.R.;Klest, H.;Kochar, V.;Korsch, W.;Kosarzewski, L.;Kotzinian, A.;Krizek, F.;Kumar, A.;Kumar, Kumar K.S.;Kumar, L.;Kumar, R.;Kumar, S.;Kunnath, A.;Kushawaha, N.;Lacey, R.;Lai, Y.S.;Lalwani, K.;Landgraf, J.;Lanza, Lanza L.;Lattuada, D.;Lavinsky, M.;Lee, J.H.;Lee, S.H.;Lemmon, R.;Lestone, A.;Lewis, N.;Li, H.;Li, S.;Li, W.;Li, W.;Li, X.;Li, X.;Liang, X.;Ligonzo, T.;Lin, T.;Liu, J.;Liu, K.;Liu, M.;Livingston, K.;Liyanage, N.;Ljubicic, T.;Long, O.;Lukow, N.;Ma, Y.;Mammei, J.;Mammoliti, F.;Mamo, K.;Mandjavidze, I.;Maple, S.;Marchand, D.;Margotti, A.;Markert, C.;Markowitz, P.;Marshall, T.;Martin, A.;Marukyan, H.;Mastroserio, A.;Mathew, S.;Mayilyan, S.;Mayri, C.;McEneaney, McEneaney M.;Mei, Y.;Meng, L.;Méot, F.;Metcalfe, J.;Meziani, Z.-E.;Mihir, P.;Milton, R.;Mirabella, A.;Mirazita, Mirazita M.;Mkrtchyan, A.;Mkrtchyan, H.;Mohanty, B.;Mondal, Mondal M.;Morreale, A.;Movsisyan, A.;Muenstermann, D.;Mukherjee, A.;Munoz, Camacho C.;Murray, Murray M.J.;Mustafa, H.;Myška, Myška M.;Nachman, B.P.;Nagai, K.;Naik, R.;Naim, J.P.;Nam, J.;Nandi, B.;Nappi, E.;Nasim, M.;Neff, D.;Neiret, D.;Newman, P.R.;Nguyen, M.;Niccolai, S.;Nie, M.;Noferini, F.;Norman, J.;Noto, F.;Nunes, A.S.;O'Connor, T.;Odyniec, G.;Okorokov, V.A.;Osipenko, M.;Page, B.;Palatchi, C.;Palmer, D.;Palni, Palni P.;Pandey, S.;Panzieri, D.;Park, S.;Paschke, K.;Pastore, C.;Patra, R.N.;Paul, A.;Paul, S.;Pecar, C.;Peck, A.;Pegg, I.;Pellegrino, C.;Peng, C.;Pentchev, L.;Perrino, R.;Piotrzkowski, K.;Polakovic, T.;Płoskoń, M.;Posik, M.;Prasad, S.;Preghenella, R.;Priens, S.;Prifti, E.;Przybycien, M.;Pujahari, Pujahari P.;Quintero, A.;Radici, M.;Radhakrishnan, S.K.;Rahman, S.;Rathi, S.;Raue, B.;Reed, Reed R.;Reimer, P.;Reinhold, J.;Renner, E.;Rignanese, L.;Ripani, M.;Rizzo, A.;Romanov, D.;Roy, A.;Rubini, N.;Ruspa, M.;Ruan, L.;Sabatié, F.;Sadhukhan, Sadhukhan S.;Sahoo, N.;Sahu, P.;Samuel, D.;Sarkar, A.;Sarsour, M.;Schmidke, W.;Schmookler, B.;Schwarz, C.;Schwiening, J.;Scott, M.;Sedgwick, I.;Segreti, M.;Sekula, Sekula S.;Seto, R.;Shah, N.;Shahinyan, A.;Sharma, D.;Sharma, N.;Sichtermann, E.P.;Signori, A.;Singh, A.;Singh, B.K.;Singh, Singh S.N.;Smirnov, N.;Sokhan, D.;Soltz, R.;Sondheim, W.;Spinali, Spinali S.;Stacchi, F.;Staszewski, R.;Stepanov, P.;Strazzi, Strazzi S.;Stroe, I.R.;Sun, X.;Surrow, B.;Sweger, Z.;Symons, T.J.;Tadevosyan, V.;Tang, A.;Tassi, E.;Teodorescu, L.;Tessarotto, F.;Thomas, D.;Thomas, J.H.;Toll, Toll T.;Tomášek, L.;Torales-Acosta, F.;Tribedy, P.;Triloki;Tripathi, V.;Trotta, R.;Trzebiński, M.;Trzeciak, B.A.;Tsai, O.;Tu, Z.;Turrisi, R.;Tuvè, C.;Ullrich, T.;Urciuoli, G.M.;Valentini, A.;Vallarino, S.;Vandenbroucke, M.;Vanek, J.;Vino, G.;Volpe, G.;Voskanyan, H.;Vossen, A.;Voutier, E.;Wang, G.;Wang, Y.;Watts, D.;Wickramaarachchi, N.;Wilson, F.;Wong, C.-P.;Wu, X.;Wu, Y.;Xie, J.;Xu, Q.-H.;Xu, Z.;Xu, Z.W.;Yang, C.;Yang, Q.;Yang, Yang Y.;Ye, Z.;Ye, Z.;Yi, L.;Yin, Z.;Yurov, M.;Zachariou, N.;Zhang, J.;Zhang, Y.;Zhang, Zhang Z.;Zhang, Zhang Z.;Zhao, Y.;Zhao, Y.X.;Zhao, Zhao Z.;Zheng, L.;Żurek, M. |
| 國立成功大學 |
2020-12-1 |
Athermal and thermal coupling electromigration effects on the microstructure and failure mechanism in advanced fine-pitch Cu interconnects under extremely high current density
|
Liang;Chien-Lung;Lin;Yung-Sheng;Kao;Chin-Li;Tarng;David;Wang;Shan-Bo;Hung;Yun-Ching;Lin;Gao-Tian;Lin;Kwang-Lung |
| 國立成功大學 |
2005-01-03 |
Athermal fibre Bragg grating strain gauge with metal coating in measurement of thermal expansion coefficient
|
Lo, Yu-Lung; Lin, Yong-Chang; Chen, Yung-Mien |
| 國立成功大學 |
2019-02-1 |
Athermal recrystallization behavior of (Sn) solid-solution at an intermetallic-free Cu/Sn interface induced by room temperature electromigration
|
Liang;Chien-Lung;Lin;Kwang-Lung |
| 國立成功大學 |
2020 |
Athermal Silicon Power Splitter using Shortcuts to Adiabaticity
|
Chung, H.-C.;Wang, T.-C.;Lu, G.-X.;Wu, C.-H.;Hung, Y.-J.;Tseng, S.-Y. |
| 臺大學術典藏 |
2018-09-10T06:27:56Z |
Atheroembolic occlusion of the left axillary artery after percutaneous transluminal coronary angioplasty
|
Chen, G.-Y.;Tseng, C.-D.;Hsu, K.-L.;Chiang, F.-T.;Lo, H.-M.;Tseng, Y.-Z.;Tsai, C.-H.; FU-TIEN CHIANG |
| 臺大學術典藏 |
2021-03-11T04:30:39Z |
Atheroembolic occlusion of the left axillary artery after percutaneous transluminal coronary angioplasty
|
Chen G.-Y.;Tseng C.-D.;Hsu K.-L.;Fu-Tien Chiang;Lo H.-M.;Tseng Y.-Z.;Tsai C.-H.; Chen G.-Y.; Tseng C.-D.; Hsu K.-L.; FU-TIEN CHIANG; Lo H.-M.; Tseng Y.-Z.; Tsai C.-H. |
| 國立臺灣大學 |
1988 |
ATHEROGENICITY AND CARCINOGENICITY OF HIGH - ARSENIC ARTESIAN WELL WATER (MULTIPLE RISK FACTORS AND RELATED MALIGNANT NEOPLASMS OF BLACKFOOT DISEASE)
|
CHEN, CHIEN-JEN; WANG, JUNG-DER; CHENG, SHOU-HSIA; WU, HSIN-YING; 陳建仁; 王榮德; 鄭守夏; 吳新英 |
| 國立臺灣大學 |
1988 |
Atherogenicity and Carcinogenicity of High-Arsenic Artesian Well Water: Multiple Risk Factors and Related Malignant Neoplasms of Blackfoot Disease
|
王榮德; 陳建仁; Wu, M. M.; Lee, S. S.; 鄭守夏; 吳新英; Hsieh, F. J.; 王榮德; 陳建仁; Wu, M. M.; Lee, S. S.; 鄭守夏; Wu, Hsin-Ying; Hsieh, F. J. |
| 國立臺灣大學 |
1988 |
Atherogenicity and Carcinogenicity of High-arsenic Artesian Well Water: Multiple Risk Factors and Related Malignant Neoplasms of Blackfoot Disease
|
謝豐舟; 陳建仁; 吳新英; Hsieh, Fon-Jou; Chen, Chien-Jen; Wu, Hsin-Ying |
| 臺北醫學大學 |
2006 |
Atheroprotective Effects of Bioactive Components from Traditional Chinese Medicine on Endothelial Cells
|
陳識中 |
| 國立交通大學 |
2019-06-03T01:08:31Z |
Atheroprotective Flow Upregulates ITPR3 (Inositol 1,4,5-Trisphosphate Receptor 3) in Vascular Endothelium via KLF4 (Kruppel-Like Factor 4)-Mediated Histone Modifications
|
He, Ming; Huang, Tse-Shun; Li, Shuai; Hong, Hsiao-Chin; Chen, Zhen; Martin, Marcy; Zhou, Xin; Huang, Hsi-Yuan; Su, Shu-Han; Zhang, Jiao; Wang, Wei-Ting; Kang, Jian; Huang, Hsien-Da; Zhang, Jin; Chien, Shu; Shyy, John Y. -J. |
顯示項目 212526-212575 / 2348638 (共46973頁)
<< < 4246 4247 4248 4249 4250 4251 4252 4253 4254 4255 > >>
每頁顯示[10|25|50]項目
|
